NasdaqGM - Nasdaq Real Time Price USD

Tevogen Bio Holdings Inc. (TVGN)

Compare
1.0209 -0.0091 (-0.88%)
As of 12:49:37 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
39,581.4920
2,273.9700
953.0830
4,618.4620
Operating Income
-39,581.4920
-2,273.9700
-953.0830
-4,618.4620
Net Non Operating Interest Income Expense
464.5570
-256.0310
--
-598.5020
Other Income Expense
91,672.2300
2,462.6760
5,361.4440
-10,379.8340
Pretax Income
52,555.2950
-67.3250
4,408.3610
-15,596.7980
Net Income Common Stockholders
55,913.6020
-67.3250
4,408.3610
-15,596.7980
Diluted NI Available to Com Stockholders
55,913.6020
-67.3250
4,408.3610
-15,596.7980
Basic EPS
0.35
-0.00
0.04
-0.13
Diluted EPS
0.35
-0.00
0.04
-0.13
Basic Average Shares
170,646.8640
165,421.0840
119,999.9890
119,999.9890
Diluted Average Shares
170,646.8640
165,421.0840
119,999.9890
119,999.9890
Total Operating Income as Reported
--
--
-13,724.0640
-4,618.4620
Total Expenses
39,581.4920
2,273.9700
953.0830
4,618.4620
Net Income from Continuing & Discontinued Operation
52,495.2950
-67.3250
4,408.3610
-15,596.7980
Normalized Income
56,468.4523
-2,530.0010
172.8202
-15,596.7980
Interest Expense
-464.5570
256.0310
--
598.5020
Net Interest Income
464.5570
-256.0310
--
-598.5020
EBIT
52,090.7380
188.7060
4,408.3610
-14,998.2960
EBITDA
52,090.7380
188.7060
4,408.3610
-14,988.9190
Reconciled Depreciation
--
--
230.8230
9.3770
Net Income from Continuing Operation Net Minority Interest
52,495.2950
-67.3250
4,408.3610
-15,596.7980
Total Unusual Items Excluding Goodwill
-5,029.3130
2,462.6760
5,361.4440
--
Total Unusual Items
-5,029.3130
2,462.6760
5,361.4440
--
Normalized EBITDA
57,120.0510
-2,273.9700
-953.0830
-14,988.9190
Tax Rate for Calcs
0.0002
--
0.0002
--
Tax Effect of Unusual Items
-1,056.1557
--
1,125.9032
--
12/31/2021 - 1/5/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NKGN NKGen Biotech, Inc.
0.6900
-3.27%
 
BDRX Biodexa Pharmaceuticals Plc
4.1292
-1.92%
 
CERO CERo Therapeutics Holdings, Inc.
0.0568
-5.32%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.8901
-3.77%
 
ALLR Allarity Therapeutics, Inc.
1.0650
-1.39%
 
SPRC SciSparc Ltd.
0.4451
+3.75%
 
ENSC Ensysce Biosciences, Inc.
8.59
-3.28%
 
GRI GRI Bio, Inc.
0.7850
+1.00%
 
COEP Coeptis Therapeutics Holdings, Inc.
0.1550
-14.93%
 
PHIO Phio Pharmaceuticals Corp.
1.8700
-3.11%